-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Chemours, Raises Price Target to $29

Benzinga·05/11/2026 16:02:17
Listen to the news
RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and raises the price target from $26 to $29.